Literature DB >> 25519717

Serum MicroRNAs as Diagnostic Biomarkers for Macrosomia.

Hua Jiang1, Yang Wen2, Lingmin Hu3, Tingting Miao3, Ming Zhang3, Jing Dong2.   

Abstract

BACKGROUND: Macrosomia is defined as an infant's birth weight of more than 4000 g. Although microRNAs (miRNAs) have been implicated in the pathogenesis of various diseases, the associations between serum miRNAs and macrosomia have been rarely reported.
METHODOLOGY: We used the Taqman Low Density Array followed by quantitative reverse transcriptase polymerase chain reaction assays to screen for miRNAs associated with macrosomia using serum samples collected 1 week before delivery.
RESULTS: Profiling results showed that 1 miRNA was significantly upregulated and 10 miRNAs were significantly downregulated in serum samples of macrosomia (ΔΔCt > 3-fold). The expression levels of miR-21 were significantly decreased in macrosomia as compared to the controls in the third trimester. Receiver operating characteristic (ROC) curve analyses showed that the area under the ROC curve for miR-21 was 67.7% (sensitivity = 66.7% and specificity = 70.0%).
CONCLUSIONS: miR-21 in maternal serum is differentially expressed between macrosomia and controls, and miR-21 could be used as a candidate biomarker to predict macrosomia.
© The Author(s) 2014.

Entities:  

Keywords:  TLDA; biomarker; macrosomia; microRNA; serum

Mesh:

Substances:

Year:  2014        PMID: 25519717      PMCID: PMC4502808          DOI: 10.1177/1933719114561557

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  36 in total

1.  [Prevalence and characteristic of overweight and obesity among adults in China, 2010].

Authors:  Xiao-yan Li; Yong Jiang; Nan Hu; Yi-chong Li; Mei Zhang; Zheng-jing Huang; Wen-hua Zhao
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2012-08

2.  Sonographic biometry in the early third trimester: A comparison of parameters to predict macrosomia at birth.

Authors:  Timothy P Canavan; Lyndon M Hill
Journal:  J Clin Ultrasound       Date:  2014-09-05       Impact factor: 0.910

3.  Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.

Authors:  Anna Zampetaki; Stefan Kiechl; Ignat Drozdov; Peter Willeit; Ursula Mayr; Marianna Prokopi; Agnes Mayr; Siegfried Weger; Friedrich Oberhollenzer; Enzo Bonora; Ajay Shah; Johann Willeit; Manuel Mayr
Journal:  Circ Res       Date:  2010-07-22       Impact factor: 17.367

4.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

5.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

Authors:  Zhibin Hu; Xi Chen; Yang Zhao; Tian Tian; Guangfu Jin; Yongqian Shu; Yijiang Chen; Lin Xu; Ke Zen; Chenyu Zhang; Hongbing Shen
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

6.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

7.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.

Authors:  Jun Shen; Nevins W Todd; Howard Zhang; Lei Yu; Xing Lingxiao; Yuping Mei; Maria Guarnera; Jipei Liao; Amy Chou; Changwan Larry Lu; Zhengran Jiang; HongBin Fang; Ruth L Katz; Feng Jiang
Journal:  Lab Invest       Date:  2010-11-29       Impact factor: 5.662

8.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

9.  Possible relation between maternal consumption of added sugar and sugar-sweetened beverages and birth weight--time trends in a population.

Authors:  Jacob Holter Grundt; Jakob Nakling; Geir Egil Eide; Trond Markestad
Journal:  BMC Public Health       Date:  2012-10-24       Impact factor: 3.295

10.  Risk factors and long-term health consequences of macrosomia: a prospective study in Jiangsu Province, China.

Authors:  Shouyong Gu; Xiaofei An; Liang Fang; Xiaomin Zhang; Chunyan Zhang; Jingling Wang; Qilan Liu; Yanfang Zhang; Yongyue Wei; Zhibin Hu; Feng Chen; Hongbing Shen
Journal:  J Biomed Res       Date:  2012-07-06
View more
  10 in total

1.  Second trimester extracellular microRNAs in maternal blood and fetal growth: An exploratory study.

Authors:  Rodosthenis S Rodosthenous; Heather H Burris; Alison P Sanders; Allan C Just; Alexandra E Dereix; Katherine Svensson; Maritsa Solano; Martha M Téllez-Rojo; Robert O Wright; Andrea A Baccarelli
Journal:  Epigenetics       Date:  2017-09-26       Impact factor: 4.528

2.  Pregnancy-associated changes in cervical noncoding RNA.

Authors:  Kristin D Gerson; Miriam J Haviland; Dayna Neo; Jonathan L Hecht; Andrea A Baccarelli; Kasey Jm Brennan; Alexandra E Dereix; Steven J Ralston; Michele R Hacker; Heather H Burris
Journal:  Epigenomics       Date:  2020-08-18       Impact factor: 4.778

3.  Physical activity and epigenetic biomarkers in maternal blood during pregnancy.

Authors:  Sylvia E Badon; Alyson J Littman; Kwun Chuen Gary Chan; Mahlet G Tadesse; Patricia L Stapleton; Theo K Bammler; Tanya K Sorensen; Michelle A Williams; Daniel A Enquobahrie
Journal:  Epigenomics       Date:  2018-10-16       Impact factor: 4.778

4.  Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus.

Authors:  Carmen Pheiffer; Stephanie Dias; Paul Rheeder; Sumaiya Adam
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

5.  Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.

Authors:  Qian Yang; Wen-Wen Gu; Yan Gu; Na-Na Yan; Yan-Yan Mao; Xing-Xing Zhen; Jian-Mei Wang; Jing Yang; Hui-Juan Shi; Xuan Zhang; Jian Wang
Journal:  J Transl Med       Date:  2018-07-04       Impact factor: 5.531

Review 6.  A Big Role for microRNAs in Gestational Diabetes Mellitus.

Authors:  Matladi Masete; Stephanie Dias; Nompumelelo Malaza; Sumaiya Adam; Carmen Pheiffer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

7.  The role, mechanism and potentially novel biomarker of microRNA-17-92 cluster in macrosomia.

Authors:  Jing Li; Liping Chen; Wei Wu; Yankai Xia; Daozhen Chen; Yali Hu; Xinru Wang
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

8.  Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis.

Authors:  Haifeng Ding; Jia Meng; Wei Zhang; Zhangming Li; Wenjing Li; Mingming Zhang; Ying Fan; Qiujun Wang; Yina Zhang; Lihong Jiang; Wenliang Zhu
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

Review 9.  The Role of miRNAs as Biomarkers for Pregnancy Outcomes: A Comprehensive Review.

Authors:  Martina Barchitta; Andrea Maugeri; Annalisa Quattrocchi; Ottavia Agrifoglio; Antonella Agodi
Journal:  Int J Genomics       Date:  2017-08-13       Impact factor: 2.326

10.  Interventricular Septal Thickness as a Diagnostic Marker of Fetal Macrosomia.

Authors:  Bartosz Szmyd; Małgorzata Biedrzycka; Filip Franciszek Karuga; Magdalena Rogut; Iwona Strzelecka; Maria Respondek-Liberska
Journal:  J Clin Med       Date:  2021-03-01       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.